Last Price | 31.88 | Max Price | 107.06 |
Min Price | 31.88 | 1 Year return | -72.36 |
Sector | Consumer Goods | Subsector | Personal Goods |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 714 | 849,130 | 0.08 % |
2020 | 935 | 763,401 | 0.12 % |
2021 | 1,526 | 886,986 | 0.17 % |
2022 | 1,599 | 1,018,101 | 0.16 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
Over the period from December 2015 till December 2016 the stock gained around 35 percent. Over the period 2011-2016 the stock rose a massive 192,9 percent. Medifast Inc's revenues between 2011 and 2015 were relatively stable and moved between 356,71 million dollars and 272,77 million dollars. Medifast Inc's net results between 2011 and 2015 were relatively stable and moved between 18,54 million dollars and 19,57 million dollars.
Medifast Inc's core business is the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent worldwide over the last 10 years. Since 2011 the sector is 147 percent higher and over the past year minus 75 percent.
The American company paid out dividends in the past 5 years. On average Medifast Inc's dividend yield over the past 5 years was around 0,25 percent annually.
At the end of 2015 the American company had a balance sheet of 117,33 million dollars. The total debt was around 28,75 million dollars. This is 24,5 percent of the total balance sheet. As per the end of 2015 Medifast Inc's price/earnings-ratio equaled 19. So investors paid for 1 stock 19 times the earnings per share of 2015. Based on the classical stock valuation theories the American stock can be seen as a value stock.
At the end of 2015 the American company's market capitalization equaled around 354,35 million dollars. At the end of 2015 the American company had around 11,96 million stocks listed.
All the annual reports of Medifast Inc are available here. More information about Medifast Inc can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
273
|
275
|
302
|
501
|
714
|
935
|
Costs |
253
|
257
|
274
|
445
|
636
|
832
|
Profit |
20
|
18
|
28
|
56
|
78
|
103
|
Margin of profit |
7.35
|
6.50
|
9.19
|
11.14
|
10.92
|
11.00
|
ROI |
22.65
|
18.58
|
25.53
|
51.13
|
74.33
|
65.41
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
89
|
96
|
109
|
109
|
105
|
157
|
Debt |
28
|
25
|
37
|
60
|
90
|
119
|
Total assets |
116
|
121
|
146
|
169
|
195
|
276
|
Solvency |
76.28
|
79.21
|
74.41
|
64.40
|
53.86
|
56.96
|
Cash |
67
|
77
|
99
|
101
|
93
|
174
|
Cashflow |
29
|
25
|
43
|
61
|
84
|
145
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
1.07
|
1.01
|
1.16
|
1.01
|
0.94
|
1.22
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
30.38
|
41.63
|
69.81
|
125.02
|
109.58
|
Eps |
1.49
|
2.29
|
4.62
|
6.43
|
8.68
|
Price/earnings-ratio |
20.39
|
18.18
|
15.11
|
19.44
|
3.67
|
Dividend |
1.07
|
1.44
|
2.19
|
3.38
|
4.52
|
Dividend % |
3.52 %
|
3.46 %
|
3.14 %
|
2.70 %
|
14.18 %
|
Payout % |
0.72
|
0.63
|
0.47
|
0.53
|
0.52
|
Book value |
8.09
|
9.07
|
9.19
|
8.91
|
13.36
|
Market to book |
0.27
|
0.22
|
0.13
|
0.07
|
0.42
|
Cashflow per stock |
2.14
|
3.61
|
5.12
|
7.16
|
12.33
|
Stocks |
12
|
12
|
12
|
12
|
12
|
Market Cap |
360.64
|
498.35
|
828.51
|
1.470.74
|
375.29
|
Date
|
Price
|
---|---|
22 Apr 2024
|
31.88
|
18 Apr 2024
|
31.88
|
17 Apr 2024
|
32.25
|
09 Apr 2024
|
34.05
|
05 Apr 2024
|
33.88
|
03 Apr 2024
|
35.12
|
30 Mar 2024
|
38.32
|
22 Mar 2024
|
35.64
|
18 Mar 2024
|
35.85
|
15 Mar 2024
|
34.57
|
12 Mar 2024
|
37.66
|
11 Mar 2024
|
39.66
|
09 Mar 2024
|
39.66
|
07 Mar 2024
|
38.04
|
01 Mar 2024
|
40.09
|
29 Feb 2024
|
40.57
|
27 Feb 2024
|
40.56
|
22 Feb 2024
|
40.38
|
21 Feb 2024
|
48.93
|
20 Feb 2024
|
49.99
|
15 Feb 2024
|
52.68
|
14 Feb 2024
|
52.88
|
13 Feb 2024
|
56.13
|
09 Feb 2024
|
54.68
|
08 Feb 2024
|
54.05
|
07 Feb 2024
|
53.87
|
06 Feb 2024
|
51.67
|
05 Feb 2024
|
53.04
|
01 Feb 2024
|
54.65
|
31 Jan 2024
|
56.87
|